These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10344268)

  • 21. Synaptic remodeling and free radical formation after brain contusion injury in the rat.
    Jørgensen OS; Hansen LI; Hoffman SW; Fülöp Z; Stein DG
    Exp Neurol; 1997 Apr; 144(2):326-38. PubMed ID: 9168833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia.
    Thompson PM; Sower AC; Perrone-Bizzozero NI
    Biol Psychiatry; 1998 Feb; 43(4):239-43. PubMed ID: 9513732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease.
    Keating DJ; Dubach D; Zanin MP; Yu Y; Martin K; Zhao YF; Chen C; Porta S; Arbonés ML; Mittaz L; Pritchard MA
    Hum Mol Genet; 2008 Apr; 17(7):1020-30. PubMed ID: 18180251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased phosphoglycerate kinase in the brains of patients with Down's syndrome but not with Alzheimer's disease.
    Labudova O; Kitzmueller E; Rink H; Cairns N; Lubec G
    Clin Sci (Lond); 1999 Mar; 96(3):279-85. PubMed ID: 10029564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortex.
    Gylys KH; Fein JA; Yang F; Miller CA; Cole GM
    Neurobiol Aging; 2007 Jan; 28(1):8-17. PubMed ID: 16332401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain site-specific gene expression analysis in Alzheimer's disease patients.
    Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
    Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome.
    Mito T; Becker LE
    Exp Neurol; 1993 Apr; 120(2):170-6. PubMed ID: 8491278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc transporter mRNA levels in Alzheimer's disease postmortem brain.
    Beyer N; Coulson DT; Heggarty S; Ravid R; Hellemans J; Irvine GB; Johnston JA
    J Alzheimers Dis; 2012; 29(4):863-73. PubMed ID: 22349685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease.
    Yoo BC; Kim SH; Cairns N; Fountoulakis M; Lubec G
    Biochem Biophys Res Commun; 2001 Jan; 280(1):249-58. PubMed ID: 11162507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetal life in Down syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure.
    Weitzdoerfer R; Dierssen M; Fountoulakis M; Lubec G
    J Neural Transm Suppl; 2001; (61):59-70. PubMed ID: 11771761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease.
    Jørgensen OS; Brooksbank BW; Balázs R
    J Neurol Sci; 1990 Aug; 98(1):63-79. PubMed ID: 1977892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease.
    Adlard PA; West AK; Vickers JC
    Neurobiol Dis; 1998 Nov; 5(5):349-56. PubMed ID: 10069577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease.
    Mastrogiacoma F; Lindsay JG; Bettendorff L; Rice J; Kish SJ
    Ann Neurol; 1996 May; 39(5):592-8. PubMed ID: 8619544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease.
    Shimohama S; Chachin M; Taniguchi T; Hidaka H; Kimura J
    Brain Res; 1996 Apr; 716(1-2):233-6. PubMed ID: 8738246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of synaptophysin and synaptosomal-associated protein 25-kDa (SNAP-25) in elderly Down syndrome individuals.
    Downes EC; Robson J; Grailly E; Abdel-All Z; Xuereb J; Brayne C; Holland A; Honer WG; Mukaetova-Ladinska EB
    Neuropathol Appl Neurobiol; 2008 Feb; 34(1):12-22. PubMed ID: 18005332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alzheimer's disease: the glial reaction is general and severe in all areas of the central nervous system].
    Delacourte A; Buée L
    C R Acad Sci III; 1989; 308(13):359-65. PubMed ID: 2496895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease.
    Vlkolinský R; Cairns N; Fountoulakis M; Lubec G
    Neurobiol Aging; 2001; 22(4):547-53. PubMed ID: 11445254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of rat brain synaptic proteins in development and aging.
    Shimohama S; Fujimoto S; Sumida Y; Akagawa K; Shirao T; Matsuoka Y; Taniguchi T
    Biochem Biophys Res Commun; 1998 Oct; 251(1):394-8. PubMed ID: 9790966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased RNA levels of the 25 kDa synaptosomal associated protein in brain samples of adult patients with Down Syndrome.
    Greber-Platzer S; Fleischmann C; Nussbaumer C; Cairns N; Lubec G
    Neurosci Lett; 2003 Jan; 336(2):77-80. PubMed ID: 12499044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains.
    Sze CI; Bi H; Kleinschmidt-DeMasters BK; Filley CM; Martin LJ
    J Neurol Sci; 2000 Apr; 175(2):81-90. PubMed ID: 10831767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.